by nikki mann | Apr 18, 2024 | News
This year the Milner Institute was delighted to take part in the University of Cambridge’s interdisciplinary Cambridge Festival. The Festival takes place each Spring and includes a mixture of online, on-demand and in-person events covering all aspects of the...
by nikki mann | Mar 26, 2024 | News
The functional genomics screening laboratory (FGSL), a joint venture between our Institute at the University of Cambridge, the Medical Research Council (MRC) and AstraZeneca, has opened a call for project proposals. The call, which opened on 26th March, is relevant to...
by nikki mann | Mar 4, 2024 | News
We are delighted that our Head of Computational Biology and AI, Dr Namshik Han, was featured on Cytiva’s ‘Discovery Matters’ podcast series last month. Cytiva – a Milner affiliated company – use their podcast series to bring together experts from across the life...
by nikki mann | Nov 30, 2023 | News
We are delighted to announce that our Frame Shift Bio-incubator has expanded this month, with the opening of a second hub in the city centre, based at the Gurdon Institute. The Frame Shift – City Centre hub will allow further growth for selected companies before they...
by nikki mann | Nov 29, 2023 | News
Last week colleagues from the Milner Institute and Korea Research Institute of Bioscience and Biotechnology (KRIBB) celebrated the signing of a new Memorandum of Understanding (MoU) that will open up exciting possibilities for collaboration. The new agreement...
by nikki mann | Nov 28, 2023 | News
We are delighted to announce a new partnership with AstraZeneca and the Medical Research Council (MRC) that will establish a new state-of-the-art functional genomics laboratory at the Milner Therapeutics Institute. This marks a significant step forward in our mission...